# Plain Language Summary: Second Chance for Moms Act

This bill would require mifepristone—a medication used for medication-induced abortion—to carry a warning label telling women that the drug's effects can supposedly be reversed with natural progesterone. The label would also direct women to call a new government hotline for more information. The bill would give the federal government six months after it becomes law to implement this labeling requirement.

The bill also creates a mandate for a 24/7 toll-free hotline that women could call if they've taken mifepristone and want information about potentially reversing its effects. The government would either run this hotline directly or contract with an organization to operate it.

In practical terms, this would primarily affect women who have taken mifepristone and are having second thoughts, as well as healthcare providers who dispense the medication. The warning label would be required on all mifepristone packaging. It's important to note that the scientific consensus on whether progesterone can actually reverse mifepristone's effects is contested—while the bill claims medical evidence supports this, major medical organizations have different views on the effectiveness and safety of this approach. The hotline would serve as a resource for women seeking information about this option, though what specific medical guidance it would provide isn't detailed in the bill itself.